Relevant bibliographies by topics / Clifton Hospital (York, England)

Contents

  1. Journal articles
  2. Books
  3. Book chapters

Academic literature on the topic 'Clifton Hospital (York, England)'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Clifton Hospital (York, England).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Clifton Hospital (York, England)"

1

MTH. "Patrick Joseph Gerard Quinn, formerly Physician Superintendent, Clifton Hospital, York." Psychiatric Bulletin 13, no. 4 (April 1989): 216. http://dx.doi.org/10.1192/pb.13.4.216.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Calder, Dale R. "The Reverend Thomas Hincks FRS (1818–1899): taxonomist of Bryozoa and Hydrozoa." Archives of Natural History 36, no. 2 (October 2009): 189–217. http://dx.doi.org/10.3366/e0260954109000941.

Full text
Abstract:
Thomas Hincks was born 15 July 1818 in Exeter, England. He attended Manchester New College, York, from 1833 to 1839, and received a B.A. from the University of London in 1840. In 1839 he commenced a 30-year career as a cleric, and served with distinction at Unitarian chapels in Ireland and England. Meanwhile, he enthusiastically pursued interests in natural history. A breakdown in his health and permanent voice impairment during 1867–68 while at Mill Hill Chapel, Leeds, forced him reluctantly to resign from active ministry in 1869. He moved to Taunton and later to Clifton, and devoted much of the rest of his life to natural history. Hincks was elected a Fellow of the Royal Society of London in 1872 for noteworthy contributions to natural history. Foremost among his publications in science were A history of the British hydroid zoophytes (1868) and A history of the British marine Polyzoa (1880). Hincks named 24 families, 52 genera and 360 species and subspecies of invertebrates, mostly Bryozoa and Hydrozoa. Hincks died 25 January 1899 in Clifton, and was buried in Leeds. His important bryozoan and hydroid collections are in the Natural History Museum, London. At least six genera and 13 species of invertebrates are named in his honour.
APA, Harvard, Vancouver, ISO, and other styles
3

Akehurst, Ann-Marie. "Wandesford Hospital, York: Colonel Moyser and the Yorkshire Burlington Group." Architectural History 51 (2008): 111–35. http://dx.doi.org/10.1017/s0066622x0000304x.

Full text
Abstract:
Richard Boyle, third Earl of Burlington (1694–1753), was a Yorkshireman, and his role in the north of England was significant, both as a designer and as an authoritative arbiter of taste. His position as Lord Lieutenant of both East and West Ridings of Yorkshire paralleled his land holdings at Londesborough near Beverley, the location of his family seat, and at Bolton Abbey, in Wharfedale. Significantly, his acceptance of a commission to supply the Corporation of the City of York, the social capital of the north, with a design for the new Assembly Rooms resulted in one of his most radical works. Burlington’s authorship of the Assembly Rooms is established, but less well known is how he also worked collaboratively in the county, alongside a group of craftsmen and gentlemen amateurs. One of these collaborators, James Moyser, can now be shown to have been responsible for the execution of Wandesford Hospital in York (Fig. 1).
APA, Harvard, Vancouver, ISO, and other styles
4

Jones, Tim, Andrew J. Carr, David Beard, Myles-Jay Linton, Leila Rooshenas, Jenny Donovan, and William Hollingworth. "Longitudinal study of use and cost of subacromial decompression surgery: the need for effective evaluation of surgical procedures to prevent overtreatment and wasted resources." BMJ Open 9, no. 8 (August 2019): e030229. http://dx.doi.org/10.1136/bmjopen-2019-030229.

Full text
Abstract:
ObjectivesTo illustrate the need for better evaluation of surgical procedures, we investigated the use and cost of subacromial decompression in England over the last decade compared with other countries and explored how this related to the conduct and outcomes of randomised, placebo-controlled clinical trials.DesignLongitudinal observational study using Hospital Episode Statistics linked to Payment by Results tariffs in England, 2007/2008 to 2016/2017.SettingHospital care in England; Finland; New York State, USA; Florida State, USA and Western Australia.ParticipantsPatients with subacromial shoulder pain.InterventionsSubacromial decompression.Main outcome measuresNational procedure rates, costs and variation between clinical commissioning groups in England.ResultsWithout robust clinical evidence, the use of subacromial decompression in England increased by 91% from 15 112 procedures (30 per 100 000 population) in 2007/2008, to 28 802 procedures (52 per 100 000 population) in 2016/2017, costing over £125 million per year. Rates of use of subacromial decompression are even higher internationally: Finland (131 per 100 000 in 2011), Florida State (130 per 100 000 in 2007), Western Australia (115 per 100 000 in 2013) and New York State (102 per 100 000 in 2006). Two randomised placebo-controlled trials have recently (2018) shown the procedure to be no more effective than placebo or conservative approaches. Health systems appear unable to avoid the rapid widespread use of procedures of unknown effectiveness, and methods for ceasing ineffective treatments are under-developed.ConclusionsWithout good evidence, nearly 30 000 subacromial decompression procedures have been commissioned each year in England, costing over £1 billion since 2007/2008. Even higher rates of procedures are carried out in countries with less regulated health systems. High quality randomised trials need to be initiated before widespread adoption of promising operative procedures to avoid overtreatment and wasted resources, and methods to prevent or desist the use of ineffective procedures need to be expedited.
APA, Harvard, Vancouver, ISO, and other styles
5

Faisal, Muhammad, Donald Richardson, Andy Scally, Robin Howes, Kevin Beatson, and Mohammed Mohammed. "Performance of externally validated enhanced computer-aided versions of the National Early Warning Score in predicting mortality following an emergency admission to hospital in England: a cross-sectional study." BMJ Open 9, no. 11 (November 2019): e031596. http://dx.doi.org/10.1136/bmjopen-2019-031596.

Full text
Abstract:
ObjectivesIn the English National Health Service, the patient’s vital signs are monitored and summarised into a National Early Warning Score (NEWS) to support clinical decision making, but it does not provide an estimate of the patient’s risk of death. We examine the extent to which the accuracy of NEWS for predicting mortality could be improved by enhanced computer versions of NEWS (cNEWS).DesignLogistic regression model development and external validation study.SettingTwo acute hospitals (YH—York Hospital for model development; NH—Northern Lincolnshire and Goole Hospital for external model validation).ParticipantsAdult (≥16 years) medical admissions discharged over a 24-month period with electronic NEWS (eNEWS) recorded on admission are used to predict mortality at four time points (in-hospital, 24 hours, 48 hours and 72 hours) using the first electronically recorded NEWS (model M0) versus a cNEWS model which included age+sex (model M1) +subcomponents of NEWS (including diastolic blood pressure) (model M2).ResultsThe risk of dying in-hospital following emergency medical admission was 5.8% (YH: 2080/35 807) and 5.4% (NH: 1900/35 161). The c-statistics for model M2 in YH for predicting mortality (in-hospital=0.82, 24 hours=0.91, 48 hours=0.88 and 72 hours=0.88) was higher than model M0 (in-hospital=0.74, 24 hours=0.89, 48 hours=0.86 and 72 hours=0.85) with higher Positive Predictive Value (PPVs) for in-hospital mortality (M2 19.3% and M0 16.6%). Similar findings were seen in NH. Model M2 performed better than M0 in almost all major disease subgroups.ConclusionsAn externally validated enhanced computer-aided NEWS model (cNEWS) incrementally improves on the performance of a NEWS only model. Since cNEWS places no additional data collection burden on clinicians and is readily automated, it may now be carefully introduced and evaluated to determine if it can improve care in hospitals that have eNEWS systems.
APA, Harvard, Vancouver, ISO, and other styles
6

Canfield, Rita. "Alternative/complementary therapies used by persons with HIV disease KM NOKES, J KENDREW, M LONGO Hunter College, City University of New York, Hunter-Bellevue School of Nursing, New York; New York Veterans Administration Medical Center; and New England Deaconess Hospital, Boston." Nutrition in Clinical Practice 11, no. 1 (February 1996): 36. http://dx.doi.org/10.1177/088453369601100114.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Yi, Deokhee, Bridget M. Johnston, Karen Ryan, Barbara A. Daveson, Diane E. Meier, Melinda Smith, Regina McQuillan, et al. "Drivers of care costs and quality in the last 3 months of life among older people receiving palliative care: A multinational mortality follow-back survey across England, Ireland and the United States." Palliative Medicine 34, no. 4 (February 3, 2020): 513–23. http://dx.doi.org/10.1177/0269216319896745.

Full text
Abstract:
Background: Care costs rise towards the end of life. International comparison of service use, costs and care experiences can inform quality and improve access. Aim: The aim of this study was to compare health and social care costs, quality and their drivers in the last 3 months of life for older adults across countries. Null hypothesis: no difference between countries. Design: Mortality follow-back survey. Costs were calculated from carers’ reported service use and unit costs. Setting: Palliative care services in England (London), Ireland (Dublin) and the United States (New York, San Francisco). Participants: Informal carers of decedents who had received palliative care participated in the study. Results: A total of 767 questionnaires were returned: 245 in England, 282 in Ireland and 240 in the United States. Mean care costs per person with cancer/non-cancer were US$37,250/US$37,376 (the United States), US$29,065/US$29,411 (Ireland), US$15,347/US$16,631 (England) and differed significantly ( F = 25.79/14.27, p < 0.000). Cost distributions differed and were most homogeneous in England. In all countries, hospital care accounted for > 80% of total care costs; community care 6%–16%, palliative care 1%–15%; 10% of decedents used ~30% of total care costs. Being a high-cost user was associated with older age (>80 years), facing financial difficulties and poor experiences of home care, but not with having cancer or multimorbidity. Palliative care services consistently had the highest satisfaction. Conclusion: Poverty and poor home care drove high costs, suggesting that improving community palliative care may improve care value, especially as palliative care expenditure was low. Major diagnostic variables were not cost drivers. Care costs in the United States were high and highly variable, suggesting that high-cost low-value care may be prevalent.
APA, Harvard, Vancouver, ISO, and other styles
8

Cockayne, Sarah, Caroline Fairhurst, Gillian Frost, Catherine Hewitt, Mark Liddle, Michael Zand, Heather Iles-Smith, Lorraine Green, Rachel Cunningham-Burley, and David Torgerson. "SSHeW study protocol: does slip resistant footwear reduce slips among healthcare workers? A randomised controlled trial." BMJ Open 8, no. 11 (November 2018): e026023. http://dx.doi.org/10.1136/bmjopen-2018-026023.

Full text
Abstract:
IntroductionSlips, trips and falls are common causes of injuries in the workplace. It is estimated that in Great Britain, nearly 1 million days are taken off work due to these injuries. There is some evidence to suggest this accident burden could be reduced by the use of slip resistant footwear. This protocol describes a multicentre trial investigating the effectiveness and cost-effectiveness of slip resistant footwear to prevent slips in National Health Service (NHS) staff working in clinical, general or catering environments.Methods and analysisA two-arm, randomised controlled trial conducted within England, with 4400 NHS staff, aged 18 years and above, who adhere to a dress code policy and work in a clinical, catering or general hospital environment. Participants will be randomised 1:1 to the intervention or waiting list control group. The intervention group will be offered a pair of 5-star GRIP rated slip resistant footwear. The control group will be offered the footwear at the end of the trial. The primary outcome is the incidence rate of self-reported slips in the workplace over a 14-week period, as reported via weekly text messages. Secondary outcomes include: time to first slip/fall, proportion of participants who slip and fall over 14 weeks and incidence rate of falls resulting from and not resulting from a slip in the workplace over 14 weeks. An economic evaluation will assess cost-effectiveness, in terms of cost per quality-adjusted life year gained. A nested qualitative study will explore the acceptability of the footwear and compliance.Ethics and disseminationThis protocol received a favourable ethical opinion from the University of York, Department of Health Sciences Research Governance Committee. The trial results will be published in peer-reviewed journals and at conferences. A summary of the findings will be made available to participants.Trial registration numberISRCTN33051393; Pre results.
APA, Harvard, Vancouver, ISO, and other styles
9

Roseveare, Chris. "Editorial." Acute Medicine Journal 11, no. 2 (April 1, 2012): 58. http://dx.doi.org/10.52964/amja.0546.

Full text
Abstract:
The ability to identify and discharge the low-risk patient, and to predict those cases where deterioration is likely is already a key element of the practice of acute medicine . This is an area which has been extensively examined in the past, but two articles in this edition add an interesting dimension to the literature. The use of physiological variables to calculate risk enables fluctuations in a patient’s condition over time can be monitored, allowing appropriate escalation measures to be instituted. The National Early Warning Score has already been implemented in Wales and roll-out across England is expected imminently. Austen and colleagues have highlighted some of the advantages that a standardised system will provide in comparison to their locally-developed Early Warning Score; however the problem of under-scoring due to incomplete or inaccurate recording remains and will continue until electronic solutions are more widespread. Scoring systems utilising laboratory data from admission are less useful for ongoing monitoring but could provide clinicians with an objective measure of risk at the time of initial assessment. As austerity measures bite, the pressure to direct our limited resources to the most appropriate cases will undoubtedly intensify, making this increasingly important. The rigorous quality control mechanisms in laboratories ensure the reliability of biochemical test results; furthermore most hospitals have electronic systems for recording and displaying results which limits the risk of errors from human transcription. O’Sullivan et al have utilised the extensive database from St James’ hospital in Dublin to develop a score based on a number of biochemical and haematological tests. Although this will need to be prospectively validated, retrospective analysis using a huge sample over a number of years, suggests their score may be highly predictive of good and poor outcome. This has great potential to support clinical decision making at the ‘front door’ and improve utilisation of resources. If variety is the ‘spice of life’, then Acute Medicine is certainly the ‘vindaloo’ of the modern hospital. The enormous breadth of clinical problems encountered on the AMU is apparent from the data gathered in York Hospital during the 15 months prior to April 2011. Variety is a key attraction for many junior doctors considering their career choice, at a time when many areas of hospital practice are becoming increasingly specialised. The acute medicine curriculum has ensured that trainees undertake blocks of training in respiratory medicine and cardiology, which is clearly important given that these areas reflected almost 50% of patients. However the authors highlight that the infrequency of certain problems, such as cord compression and diabetic ketoacidosis might also need to be addressed with training outside the AMU in neurology and endocrinology to ensure adequate exposure to these conditions. The rise in alcohol-related admissions is also highlighted in this article, and our trainee section includes a problem based review of the management of these problems. The obesity epidemic, as well as the proliferation of weight-loss surgery and its complications is another area which increasingly challenges our AMU resources. The article by Fiona Maggs provides some practical advice on how to address these issues. I hope you enjoy this edition, and the summer months ahead...
APA, Harvard, Vancouver, ISO, and other styles
10

Ghalehsari, Nima, Pragnan Kancharla, Neil S. Nimkar, Anita Mazloom, Farah Ashraf, Angelica Singh, and Mendel Goldfinger. "An Institutional Retrospective Study on Recognizing the Delay in Multiple Myeloma Diagnosis." Blood 134, Supplement_1 (November 13, 2019): 3430. http://dx.doi.org/10.1182/blood-2019-127625.

Full text
Abstract:
Background Multiple myeloma (MM) is the abnormal proliferation of plasma cells in the bone marrow often resulting in debilitating symptoms ranging from ostealgia to pathological fractures from bone destruction. According to American Cancer Society, MM accounts for 1-2% of cancers and approximately 17% of hematological malignancies in the United States each year (1). Fifty percent of patients with symptomatic MM have three or more primary care visits before they are referred to a specialist, which is greater than any other cancer (5). It has been shown that a delay in diagnosing multiple myeloma negatively impacts the clinical course of the disease and hence the outcome in patients (2). Patients with longer diagnostic intervals also experience shorter disease free survival and more complications from treatment (4). Herein, a retrospective analysis was performed to determine the average delay in diagnosis of MM. Methods This is a retrospective electronic chart review of all indexed newly diagnosed MM cases between 1/1/2014 through 12/31/2018 at New York-Presbyterian Brooklyn Methodist Hospital (NYP BHM). NYP BMH is a Weill Cornell Medical College-affiliated hospital in Brooklyn, NY whose patient population includes those with private insurance, uninsured and Medicare/Medicaid. Data abstraction from the electronic medical record (EMR) was uniform and involved baseline characteristics such as age, gender and race. International Classification of Diseases (ICD)-10-CM code (C90.00) was used for extraction of data which identified 492 patients. After excluding patients with MGUS or a prior diagnosis of multiple myeloma, 104 patients were included in the final study. We calculated the number of days between the date of first abnormal laboratory value seen on bloodwork for a myeloma related sign (at least 90 days prior to diagnosis) to the date of bone marrow biopsy that confirmed the diagnosis. The inclusion criteria were anemia defined as hemoglobin &lt;12gm/dl, Hypercalcemia defined by corrected calcium &gt;10, kidney dysfunction with a creatinine &gt;1.5 and total protein &gt;8. Results Of the 104 patients with newly diagnosed MM, 69 patients were diagnosed within 90 days of the first abnormal lab value recorded in our electronic medical record (EMR). Thirty-five patients (34%) had a delay in diagnosis at least 90 days with a mean delay of 38 months. Isolated anemia was the most common abnormal lab finding with 29/104 (28%) having documented anemia at least 90 days prior to diagnosis of myeloma. The mean delay in diagnosis for patients with anemia was 41 months. There were four patients with anemia and elevated creatinine with an average delay of 23 months. Five patients had anemia and elevated calcium with an average delay of 21 months. Nine patients had anemia and elevated total protein with an average delay of 38 months. Conclusion: In the current era where we have effective therapies for MM it is now more important than ever to avoid a delay in diagnosis. We demonstrate that 34% of patients receiving care at an Urban Teaching Hospital had at least a 90 day delay in their diagnosis of MM. Our cohort consisted of 64% African Americans, suggesting that minorities are more commonly affected by this. There is a need for more awareness amongst clinicians to consider the diagnosis of MM in the workup of anemia. References: 1. Kariyawasan, C. C., D. A. Hughes, M. M. Jayatillake, and A. B. Mehta. 2007. "Multiple Myeloma: Causes and Consequences of Delay in Diagnosis." QJM: Monthly Journal of the Association of Physicians 100 (10): 635-40. 2. Siegel, Rebecca L., Kimberly D. Miller, and Ahmedin Jemal. 2019. "Cancer Statistics, 2019." CA: A Cancer Journal for Clinicians. https://doi.org/10.3322/caac.21551. 3. Vélez R, Turesson I, Landgren O, Kristinsson SY, Cuzick J. Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends. BMJ Open. 2016;6:e009584. 4. Kariyawasan CC, Hughes DA, Jayatillake MM, et al. Multiple myeloma: causes and consequences of delay in diagnosis. QJM 2007;100:635-40. 10.1093/qjmed/hcm077 5. Lyratzopoulos G, Neal RD, Barbiere JM, et al. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol 2012;13:353-65. 10.1016/S1470-2045(12)70041-4 Disclosures No relevant conflicts of interest to declare.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Clifton Hospital (York, England)"

1

Haslam, M. T. Clifton Hospital: An era. Belper: Golden FlowerPress, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

From York lunatic asylum to Bootham Park Hospital. [York]: University of York, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cullum, P. H. Cremetts and corrodies: Care of the poor and sick at St. Leonard's hospital, York, in the Middle Ages. [York]: University of York, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Assembly, Canada Legislature Legislative. Bill: An act to incorporate the General Hospital of the District of Richelieu. Quebec: Thompson, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Assembly, Canada Legislature Legislative. Bill: An act to amend the charter of the Society of the Montreal General Hospital. Toronto: J. Lovell, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Assembly, Canada Legislature Legislative. Bill: An act to establish and continue a survey in the township of King, in the county of York. Quebec: Thompson, Hunter, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Assembly, Canada Legislature Legislative. Bill: An act providing for the separation of the city of Toronto from the united counties of York and Peel, for judicial purposes. Quebec: Thompson, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Assembly, Canada Legislature Legislative. Bill: An act to provide for the separation of the city of Toronto from the united counties of York and Peel for judicial purposes. Quebec: Thompson, Hunter, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Assembly, Canada Legislature Legislative. Bill: An act to repeal two certain acts therein mentioned relating to the separation of the county of Peel from the county of York, and for other purposes. Quebec: Thompson, Hunter, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Assembly, Canada Legislature Legislative. Bill: An act to extend to the counties of Wentworth and Lincoln, the act for the protection of persons owning lands on the shore of Lake Ontario, in the counties of York, Peel and Halton. Quebec: Hunter, Rose, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Clifton Hospital (York, England)"

1

Shorter, Edward. "Things Get Rolling." In The Rise and Fall of the Age of Psychopharmacology, edited by Edward Shorter, 43–58. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780197574430.003.0004.

Full text
Abstract:
The take-off of psychopharmacology in the mental-hospital world began in the vast asylum system of New York State in the early 1950s. Henry Brill ordered the state system to introduce chlorpromazine in 1955, which led to the first decrease in the census of the state asylum system in peacetime. Sidney Merlis and Herman Denber implemented chlorpromazine in their hospitals and, with Brill, began a series of publications on the drugs and their efficacy. Pharmacologist and psychiatrist Joel Elkes established the first department of experimental psychiatry in the world in 1951 at the University of Birmingham in England. Finally, the chapter examiunes the historical heft of the National Institute of Mental Health, which in 1953 opened the “intramural” (in-house) research program where much of the research in psychopharmacology done in the United States has occurred.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Clifton Hospital (York, England)' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography